NSPR Stock Analysis: Buy, Sell, or Hold?
NSPR - InspireMD, Inc.
$0.90
0.00 (-0.01%)
▼
5d:
-8.41%
30d:
+29.49%
90d:
-12.64%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 17, 2026
0d
Get Alerted When NSPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: NSPR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: NSPR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: NSPR is currently trading at $0.90, which is considered extended relative to its 30-day fair value range of $0.66 to $0.82.
Technical Outlook: Technically, NSPR is in a strong downtrend. Immediate support is located at $0.74, while resistance sits at $1.02.
Market Sentiment: NSPR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.33 (+270.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, NSPR is in a strong downtrend. Immediate support is located at $0.74, while resistance sits at $1.02.
Market Sentiment: NSPR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $3.33 (+270.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$0.66 -
$0.82
Company Quality Score
26/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
All Signals
- BEARISH: Price extended above range (+9.7% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 270.4% below Wall St target ($3.33)
- WARNING: Composite score 26/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.66 -
$0.82
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$0.74
Resistance Level
$1.02
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.86
Wall Street Target
$3.33
(+270.4%)
Revenue Growth (YoY)
122.2%
Share & Embed Analysis
Last updated: August 24, 2026 8:45 AM ET
Data refreshes hourly during market hours. Next update: 9:45 AM
Data refreshes hourly during market hours. Next update: 9:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 48 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 31 SELL |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 37 SELL |
